https://www.thebodypro.com/category/hiv-treatments-in-development/tag/china

The Latest

China Approves Albuvirtide: A Once-Weekly Injectable Entry Inhibitor Img

China Approves Albuvirtide: A Once-Weekly Injectable Entry Inhibitor

On June 6, 2018, without news from the U.S. FDA, a press release from Frontier Biotech announced the approval of a new HIV drug in China that is given by once-weekly injection.